Skip to main content

Table 1 Clinical Features Related to Patient Tissue Used in Microarray Analysis

From: Gene Expression in Temporal Lobe Epilepsy is Consistent with Increased Release of Glutamate by Astrocytes

Patient ID

TYPE

M/F

Age at first seizure

Age at surgery

Pathology

IH575

MTLE

M

11

51

Hippocampal Sclerosis

IH648

MTLE

F

9

32

Hippocampal Sclerosis

IH672

MTLE

F

8

61

Hippocampal Sclerosis

IH693

MTLE

F

4

34

Hippocampal Sclerosis

IH708

MTLE

M

8

27

Hippocampal Sclerosis

LA7

MTLE

F

8

52

Hippocampal Sclerosis

LA11

MTLE

M

0.5

36,5

Hippocampal Sclerosis

LA15

MTLE

M

5

35

Hippocampal Sclerosis

IH677

MaTLE

M

63

64

Oligodendroglioma

IH688

MaTLE

M

15

17

Mixed glioma, low grade

IH280

MaTLE

M

22

36

Heterotopia, Neuronal clustering. Hippocampus no cell loss.

IH689

MaTLE

M

0.008

11

Cerebral tissue with remote ischemic changes (cystic infarct) and reactive gliosis. Hippocampus no neuronal loss

IH682

MaTLE

F

0.014

6

Hippocampus no neuron loss. Cerebral cortex showing partial atrophy and focal absence, neuronal loss, and gliosis.

IH687

PTLE

M

0.75

5

No hippocampal sclerosis. Cortex and white matter with no significant histopathology.

IH671

PTLE

F

38

47

Hippocampus with mild white matter gliosis, no detectable neuronal loss.

IH453

PTLE

F

4

46

No significant neuronal loss in hippocampus.

IH653

PTLE

F

8

38

No significant neuronal loss in hippocampus.

IH707

PTLE

M

24

27

No significant neuronal loss in hippocampus

SF6

PTLE

M

8

24

No significant neuronal loss in hippocampus

  1. *The age at first seizure and the age at surgery are in years.